International Clinical Trial: Efficacy and safety of Human Bone Marrow Derived Mesenchymal in Patients with pre-acute-on-chronic liver failure

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2600116016) titled 'Efficacy and safety of Human Bone Marrow Derived Mesenchymal in Patients with pre-acute-on-chronic liver failure' on Jan. 4.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: The First Affiliated Hospital of Xi'an Jiaotong University

Condition: Pre-acute-on-chronic liver failure

Intervention: Bone marrow mesenchymal stem cell treatment group:CG-BM1 allogeneic human bone marrow mesenchymal stem cell injection

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-01-04

Target Sample Size: Bone marrow mesenchymal stem cell treatment group:33;Standardized d...